Drug Profile
BCWP D003
Alternative Names: BCWP-D003Latest Information Update: 05 Sep 2023
Price :
$50
*
At a glance
- Originator BC World Pharm
- Class Antineoplastics
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Preclinical Cancer
Most Recent Events
- 05 Sep 2023 Preclinical development is ongoing in South Korea (Unspecified route) (BC World Pharm pipeline, September 2023)
- 09 Jul 2016 Preclinical trials in Cancer in South Korea (unspecified route)